查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1824205

生物感测器市场 - 预测 2025-2030

Biosensors Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

生物感测器市场预计将从 2025 年的 370.55 亿美元成长到 2030 年的 659.17 亿美元，复合年增长率为 12.21%。

生物感测器是一种先进的诊断设备，其精密的感测技术能够准确地检测和监测各种医疗状况，使其成为现代医疗保健服务的基本工具。这些设备在血糖值监测、妊娠检测和胆固醇评估等关键医疗应用中特别有效，并已成为临床和居家医疗管理的重要组成部分。

该技术的主要优势在于它能够提供精确、即时的生物参数测量，以支援临床决策和患者自我管理通讯协定。生物感测器已成为重大健康状况的重要诊断工具，尤其是癌症检测和糖尿病管理，早期检测和持续监测对患者预后和治疗效果有重大影响。

不断扩展的应用组合反映了该技术在各种医疗保健场景中的多功能性和可靠性。医疗保健提供者越来越依赖生物感测器技术来提供快速、准确的诊断信息，以支持及时的干预策略，同时减少对需要较长处理时间和专业设施的传统实验室检测方法的依赖。

市场动态和医疗保健产业影响

生物感测器市场正呈现强劲成长势头，主要得益于其在医疗保健领域的日益普及，以及需要持续监测的慢性病发病率的不断上升。全球慢性病发病率的上升，对能够支持长期患者管理通讯协定的诊断技术的需求持续增长。

人工智慧和物联网等技术进步的融合正在增强生物感测器的功能和潜在应用，实现更复杂的数据分析、更高的诊断准确性和增强的连接性，以支援综合医疗保健系统。

医疗产业注重可携式、经济高效且反应迅速的诊断解决方案，这与生物感测器技术的特性完美契合。早期准确的疾病识别是改善患者预后和生存率的关键因素，因此对能够在各种医疗环境中提供可靠结果的先进诊断技术的需求持续增长。

随着慢性病和文明病的增多，消费者越来越倾向于定期监测致病活动，这一趋势支撑着生物感测器市场的持续成长。全球人口老化以及奈米技术的进步使得生物感测器更加普及且更具成本效益，从而将市场拓展至更广泛的患者群体。

创新与产品开发

生物感测器市场受益于检测方法和设备设计的持续创新，各公司正在开发日益复杂的解决方案来应对特定的医疗挑战。非侵入式检测技术是其发展的关键领域，基于唾液的血糖监测系统为传统的血液检测方法提供了替代方案。

先进的生物感测器设计融合了快速检测细菌和病毒的功能，能够立即评估是否需要进一步咨询或检测。此类技术透过提供早期筛检能力来指南后续的护理决策，从而简化医疗保健流程。

穿戴式生物感测器技术正展现出强劲的创新势头，其设备能够即时监测生理状况，包括水合状态和电解质成分分析。这些系统整合了蓝牙连接和行动应用程序，可提供持续的健康监测以及自动化的建议和警报，从而建立全面的健康管理解决方案。

地理市场领导与策略发展

北美凭藉着密集的企业创新活动以及包括人工智慧在内的先进技术的整合，保持着市场主导地位。区域市场的发展反映了集中的研发能力、支持创新的监管基础设施以及成熟的医疗技术应用模式。

製药公司与领先研究机构之间的策略伙伴关係关係彰显了业界对推动生物感测器技术应用的决心。这些合作致力于开发整合生物感测器、生物电子学和响应式给药系统的整合解决方案，以打造全面的医疗管理平台。

专用生物感测器应用（例如用于工业和农业的干涉测量系统）製造能力的提升，显示市场已超越传统医疗应用，走向多元化。这些发展标誌着人们日益认识到生物感测器技术在需要精确生物或化学检测能力的多个工业领域的适用性。

未来市场趋势

行业专家预测，由于技术创新、医疗应用的不断扩大以及与支持全面患者照护管理和监测解决方案的数位健康平台的日益融合，生物感测器市场将继续扩张。

本报告的主要优点

  • 深刻分析：获得深入的市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业所采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力来制定策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说，既有利又划算。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024）和预测资料（2025-2030）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司概况（策略、产品、财务资讯、主要趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概况
  • 市场定义
  • 分析范围
  • 细分市场

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章生物感测器市场（按类型）

  • 介绍
  • 电化学
  • 身体的
  • 穿戴式装置
  • 发情检测
  • 其他的

第六章生物感测器市场（按应用）

  • 介绍
  • 品管
  • 医疗诊断
  • 农药管理
  • 药物开发
  • 其他的

第七章生物感测器市场（按最终用户）

  • 介绍
  • 食品/饮料
  • 医疗/保健
  • 製药
  • 农业
  • 其他的

第八章生物感测器市场（按地区）

  • 介绍
  • 北美洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 德国
      • 法国
      • 英国
      • 义大利
      • 西班牙
      • 其他的
  • 中东和非洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 以色列
      • 其他的
  • 亚太地区
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 中国
      • 印度
      • 日本
      • 韩国
      • 印尼
      • 泰国
      • 台湾
      • 澳洲
      • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪表板

第十章：公司简介

  • Abott Laboratories
  • Bio-Rad Laboratories Inc.
  • Sartorius AG
  • Nix Biosensors
  • Universal Biosensors
  • Pinnacle Technology Inc.
  • Dexcom Inc.
  • Analog Devices, Inc.
  • STMicroelectronics
  • Malvern Panalytical Ltd（Spectris）

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 分析方法
  • 简称

图表列表

表格列表

简介目录
Product Code: KSI061614273

The biosensors market is expected to grow from USD 37.055 billion in 2025 to USD 65.917 billion in 2030, at a CAGR of 12.21%.

Biosensors represent sophisticated diagnostic instruments that have become fundamental tools in modern healthcare delivery, enabling precise detection and monitoring of various medical conditions through advanced sensing technologies. These devices demonstrate particular efficacy in critical healthcare applications including blood glucose monitoring, pregnancy detection, and cholesterol level assessment, establishing themselves as essential components in both clinical and home-based healthcare management.

The technology's primary strength lies in its capability to provide accurate, real-time biological parameter measurements that support clinical decision-making and patient self-management protocols. Biosensors have emerged as key diagnostic instruments for major health conditions, particularly cancer detection and diabetes management, where early identification and continuous monitoring significantly impact patient outcomes and treatment effectiveness.

The expanding application portfolio reflects the technology's versatility and reliability across diverse medical scenarios. Healthcare providers increasingly rely on biosensor technology to deliver rapid, accurate diagnostic information that supports timely intervention strategies while reducing dependency on traditional laboratory-based testing methods that require extended processing times and specialized facilities.

Market Growth Dynamics and Healthcare Sector Influence

The biosensors market demonstrates robust growth trajectory driven primarily by expanding healthcare sector adoption and the increasing prevalence of chronic medical conditions requiring continuous monitoring. The rising global incidence of chronic illnesses creates sustained demand for diagnostic technologies capable of supporting long-term patient management protocols.

Technological advancement integration, including artificial intelligence and Internet of Things capabilities, has enhanced biosensor functionality and expanded application possibilities. These technological convergences enable more sophisticated data analysis, improved diagnostic accuracy, and enhanced connectivity that supports integrated healthcare delivery systems.

The healthcare sector's emphasis on portable, cost-effective diagnostic solutions with rapid response capabilities aligns perfectly with biosensor technology characteristics. Early and accurate disease identification represents a critical factor in positive patient outcomes and survival rates, creating sustained demand for advanced diagnostic technologies that can deliver reliable results in diverse healthcare settings.

Consumer healthcare trends toward regular pathogenic activity monitoring, driven by increasing prevalence of chronic and lifestyle-related conditions, support sustained market growth. The combination of aging global demographics and nanotechnology advancement improves biosensor accessibility and cost-effectiveness, expanding market reach across diverse patient populations.

Innovation and Product Development

The biosensors market benefits from continuous innovation in detection methodologies and device design, with companies developing increasingly sophisticated solutions that address specific healthcare challenges. Non-invasive testing technologies represent a significant advancement area, with saliva-based glucose monitoring systems offering alternatives to traditional blood-based testing methods.

Advanced biosensor designs incorporate rapid testing capabilities for bacterial and viral detection, enabling immediate assessment of whether additional medical consultation and testing are necessary. These developments support healthcare efficiency by providing initial screening capabilities that can guide subsequent care decisions.

Wearable biosensor technology demonstrates significant innovation momentum, with devices capable of real-time physiological monitoring including hydration status and electrolyte composition analysis. These systems integrate Bluetooth connectivity and mobile applications to provide continuous health monitoring with automated recommendations and alerts, creating comprehensive health management solutions.

Geographic Market Leadership and Strategic Developments

North America maintains a dominant market position driven by concentrated corporate innovation activity and advanced technology integration including artificial intelligence implementation. Regional market leadership reflects the concentration of research and development capabilities, regulatory infrastructure supporting innovation, and established healthcare technology adoption patterns.

Strategic partnerships between pharmaceutical companies and leading research institutions demonstrate industry commitment to advancing biosensor technology applications. These collaborations focus on developing integrated solutions combining biosensors, bioelectronics, and responsive delivery systems that create comprehensive healthcare management platforms.

The expansion of manufacturing capabilities for specialized biosensor applications, including interferometric-based systems for industrial and agricultural applications, indicates market diversification beyond traditional healthcare applications. These developments suggest growing recognition of biosensor technology's applicability across multiple industry sectors requiring precise biological or chemical detection capabilities.

Future Market Trajectory

Industry experts should anticipate continued biosensors market expansion driven by technological innovation, expanding healthcare applications, and increasing integration with digital health platforms that support comprehensive patient care management and monitoring solutions.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The biosensors market has been analyzed through the following segments:

By Type

  • Electrochemical
  • Physical
  • Wearable
  • Thermal Detection
  • Others

By Application

  • Quality Control
  • Medical Diagnosis
  • Pesticide Control
  • Drug Development
  • Others

By End-User

  • Food & Beverage
  • Medical & Healthcare
  • Pharmaceutical
  • Agriculture
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Australia
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BIOSENSORS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Electrochemical
  • 5.3. Physical
  • 5.4. Wearable
  • 5.5. Thermal Detection
  • 5.6. Others

6. BIOSENSORS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Quality Control
  • 6.3. Medical Diagnosis
  • 6.4. Pesticide Control
  • 6.5. Drug Development
  • 6.6. Others

7. BIOSENSORS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Food & Beverage
  • 7.3. Medical & Healthcare
  • 7.4. Pharmaceutical
  • 7.5. Agriculture
  • 7.6. Others

8. BIOSENSORS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. ByType
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Israel
      • 8.5.4.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Australia
      • 8.6.4.9. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abott Laboratories
  • 10.2. Bio-Rad Laboratories Inc.
  • 10.3. Sartorius AG
  • 10.4. Nix Biosensors
  • 10.5. Universal Biosensors
  • 10.6. Pinnacle Technology Inc.
  • 10.7. Dexcom Inc.
  • 10.8. Analog Devices, Inc.
  • 10.9. STMicroelectronics
  • 10.10. Malvern Panalytical Ltd (Spectris)

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES